EUVIMEDEUVIMED entdecken
Crossref

Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients

Avinash Singh, Punam P Bhadani, Surabhi, Ruchi Sinha, Shreekant Bharti, Tarun Kumar, Jitendra S Nigam

Indian Journal of Pathology and Microbiology · 2023

DOI: 10.4103/ijpm.ijpm_658_21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2023. Verfasst von Avinash Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, All India Institute of Medical Sciences, Patna, Bihar, India. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The epidemic of coronavirus disease 2019 (COVID-19) has been rapidly spreading on a global scale affecting many countries and territories. There is rapid onset of generalized inflammation resulting in acute respiratory distress syndrome. We, thus, aimed to explore the potential of immune-inflammatory parameters in predicting the severity of COVID-19. Materials and Methods: Age, neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), Lactate Dehydrogenase (LDH), C-reaction protein (CRP), and procalcitonin (PCT) of 611 patients with laboratory-confirmed COVID-19 were investigated and compared. Patients were divided on the basis of severity and survival into two groups. Data were expressed as mean or median values and percentages. The receiver operating characteristic curve was applied to determine the optimal cut-off values of these biomarkers.

Results

The median age was 50 years and the male to female ratio was 3.7:1. The mean NLR, LMR, PLR, LDH, CRP, and Procalcitonin for the non-severe group were 4.16, 10.8, 133.7, 666.1, 49.9, and 0.15, respectively. In the severe group mean values of the above-mentioned immune-inflammatory markers were 17.8, 4.69, 268.2, 1277, 158.6, and 3.05, respectively. Elevated levels were significantly associated with disease severity. In ROC curve analysis, NLR had the largest area under the curve at 0.923 with the highest specificity (0.83) and sensitivity (0.88).

Conclusion

This study shows that NLR, PLR, LDH, CRP, and Procalcitonin may be a rapid, widely available, useful predictive factor for determining the severity of COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19FemaleHumansMaleMiddle AgedBiomarkersC-Reactive ProteinLymphocytesNeutrophilsProcalcitoninPrognosisRetrospective StudiesNLR ProteinsReceptors, Immunologic

Stichwörter der Autor:innen

COVID-19inflammationlymphocyteneutrophil

Substanzen

BiomarkersC-Reactive ProteinProcalcitoninNLR ProteinsCRP protein, humanReceptors, Immunologic

Autor:innen und Institutionen

  • Department of Pathology, All India Institute of Medical Sciences, Patna, Bihar, India.

Zitieren

APA

Singh, A., Bhadani, P. P., Surabhi, Sinha, R., Bharti, S., Kumar, T., & Nigam, J. S. (2023). Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_658_21

Vancouver

Singh A, Bhadani PP, Surabhi, Sinha R, Bharti S, Kumar T, et al. Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients. Indian Journal of Pathology and Microbiology. 2023. doi:10.4103/ijpm.ijpm_658_21

BibTeX
@article{Singh2023,
  author = {Singh, Avinash and Bhadani, Punam P and Surabhi and Sinha, Ruchi and Bharti, Shreekant and Kumar, Tarun and Nigam, Jitendra S},
  title = {Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2023},
  doi = {10.4103/ijpm.ijpm_658_21}
}
Kostenlos starten →